Current status and future directions of anti-angiogenic therapy for gliomas

Abstract. Molecular targets for the pathological vasculature are the vascular endothelial growth factor (VEGF)/VEGF receptor axis, integrins, angiopoietins, an

Salvato in:
Dettagli Bibliografici
Autori principali: Wick, Wolfgang (Autore) , Platten, Michael (Autore) , Wick, Antje (Autore) , Berberich, Anne (Autore) , Radbruch, Alexander (Autore) , Bendszus, Martin (Autore) , Winkler, Frank (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: 2016
In: Neuro-Oncology
Year: 2015, Volume: 18, Fascicolo: 3, Pages: 315-328
ISSN:1523-5866
DOI:10.1093/neuonc/nov180
Accesso online:Verlag, Volltext: https://doi.org/10.1093/neuonc/nov180
Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/18/3/315/2509235
Testo
Note sull'autore:Wolfgang Wick, Michael Platten, Antje Wick, Anne Hertenstein, Alexander Radbruch, Martin Bendszus, and Frank Winkler
Descrizione
Riassunto:Abstract. Molecular targets for the pathological vasculature are the vascular endothelial growth factor (VEGF)/VEGF receptor axis, integrins, angiopoietins, an
Descrizione del documento:Advance Access date 12 October 2015
Gesehen am 11.03.2020
Descrizione fisica:Online Resource
ISSN:1523-5866
DOI:10.1093/neuonc/nov180